Tirbanibulin
Tirbanibulin, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Phase 2.
| Trivial name | KX 01 |
| Catalog Number | S2700 |
| Molecular Formula | C24H28Cl2N2O4 |
| CAS# | 897016-82-9 |
| Inchi | InChI=1S/C24H27ClN2O4.ClH/c1-28-20-7-4-17(12-22(20)29-2)10-11-26-14-18-5-8-21(23(13-18)30-3)31-16-19-6-9-24(25)27-15-19;/h4-9,12-13,15,26H,10-11,14,16H2,1-3H3;1H |
| Inchi Key | QBGSVDJLQQXEGG-UHFFFAOYSA-N |
| SMILES | COC1=C(C=C(C=C1)CCNCC2=CC(=C(C=C2)OCC3=CN=C(C=C3)Cl)OC)OC.Cl |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/kx2-391.html |
| Additional Information | https://file.selleck.cn/downloads/struct/KX2-391-chemical-structure-s2700.gif |